Quick Overview
- Conagra’s fiscal Q1 2027 earnings release is scheduled for Wednesday, September 30, ahead of the opening bell.
- Wall Street forecasts revenue around $2.59 billion, representing a 2% decline year-over-year.
- Per-share earnings are projected at 31 cents, reflecting approximately 21% decrease from prior year.
- Shares hover around $14, marking a year-to-date decline of roughly 14%.
- Analyst consensus remains at Hold for CAG stock, with targets spanning $12 to $16.
Shares of Conagra Brands hover around the $14 mark as the packaged foods company prepares to unveil its fiscal first quarter financial results on Wednesday. Year-to-date performance shows CAG stock declining approximately 14%.
The Chicago-based food manufacturer, known for popular brands including Slim Jim, Birds Eye, Banquet, and Hunt’s, will release its quarterly figures before trading begins on September 30.
Financial analysts anticipate challenging results for the period. Revenue forecasts hover near $2.59 billion, representing approximately 2% contraction compared to the year-ago quarter.
Per-share profit predictions settle at 31 cents. This figure would signal roughly 21% erosion versus the comparable quarter in fiscal 2026.
Consumer behavior trends show households gravitating toward budget-friendly food alternatives. This market dynamic continues pressuring the company’s revenue generation.
Cost Pressures Weigh on Profitability
The packaged foods giant confronts elevated expenses spanning raw materials, packaging materials, and logistics. Company guidance indicates full-year inflationary headwinds between 5% and 6%.
Tariff-related expenses totaling $40 million are anticipated to create the most significant impact during this opening quarter. Leadership also intends to increase investment in marketing and promotional activities.
Annual operating margin guidance stands between 10% and 10.5%. This represents substantial compression from the company’s historical benchmark near 16%.
Specifically for the first quarter, adjusted operating margin is forecasted in the high-single-digit territory. This would represent meaningful contraction from the prior year’s 11.8% figure.
Strategic price adjustments won’t materialize at retail until the midpoint of the second quarter. This timing leaves limited opportunity to counterbalance near-term headwinds.
Wall Street Divided on Valuation
Investment analysts maintain a predominantly cautious stance on CAG stock. The consensus rating stands at Hold across 13 covering analysts, comprising one Buy recommendation, eight Hold ratings, and four Sell opinions.
Barclays analyst Andrew Lazar maintains his Buy recommendation with a $16 valuation, emphasizing dividend support as a key factor. J.P. Morgan’s Thomas Palmer assigns a Neutral stance with a $15 objective.
RBC Capital and UBS both establish $14 price objectives. Bank of America and Goldman Sachs issue Sell ratings with identical $13 targets.
Evercore ISI places its target at $12.50. Bernstein maintains Wall Street’s most conservative projection at $12, highlighting persistent margin compression and sluggish grocery sector volume expansion.
The consensus 12-month price objective averages $13.73. This suggests potential downside of approximately 3% from present trading levels.
Earlier this year, Conagra reduced its quarterly cash distribution to $0.175 per share. The strategic decision liberates approximately $1 billion across three years for manufacturing facility enhancements and supply chain infrastructure.
Management is simultaneously pursuing productivity improvements exceeding 4% of cost of goods sold throughout fiscal 2027. Incremental advertising expenditure concentrates on frozen meal offerings and meat snack products, two segments demonstrating recent volume momentum.
Zacks presently assigns Conagra a Sell ranking, accompanied by an Earnings ESP of +3.22%. The corporation’s most recent four-quarter earnings surprise record averages approximately 5%.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
